Article
Cutting down the time to identify challenging tumor therapeutic targets and drug combinations using synthetic lethal approaches
2018-03-12
Abstract excerpt
Cancer drug discoverers and developers are blessed and cursed with a plethora of drug targets in the tumor cells themselves and the surrounding stromal elements. This bounty of targets has, at least in part, inspired the rapid increase in the number of clinically available small-molecule, biological, and cellular therapies for solid and hematological malignancies. Among the most challenging questions in cancer the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6375942e-2346-59f5-98bf-2ff0c6afc3bb
- DOI
- 10.12688/f1000research.13679.1
